Evidence map›Paper›PMID 36034320›Full record

ArticleEFSA journal. European Food Safety Authority2022

Modification of the existing maximum residue levels for acetamiprid in honey and various oilseed crops.

EFSA (European Food Safety Authority), Giulia Bellisai, Giovanni Bernasconi, Alba Brancato, Luis Carrasco Cabrera, Irene Castellan, Lucien Ferreira, German Giner, Luna Greco, Samira Jarrah and 12 more

Abstract read
In one paragraph

Article in EFSA journal. European Food Safety Authority, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Modification of the existing maximum residue level for acetamiprid in honey.EFSA journal. European Food Safety Authority · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

EFSA (European Food Safety Authority)
Giulia Bellisai
Giovanni Bernasconi
Alba Brancato
Luis Carrasco Cabrera
Irene Castellan
Lucien Ferreira
German Giner
Luna Greco
Samira Jarrah
Renata Leuschner
Jose Oriol Magrans
Ileana Miron
Stefanie Nave
Ragnor Pedersen
Hermine Reich
Tobin Robinson
Silvia Ruocco
Miguel Santos
Alessia Pia Scarlato
Anne Theobald
Alessia Verani

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In accordance with Article 6 of Regulation (EC) No 396/2005, the applicant Nufarm Europe Gmbh submitted a request to the competent national authority in Austria to modify the existing maximum residue levels (MRLs) for the active substance acetamiprid in honey, linseeds, poppy seeds, mustard seeds and gold of pleasure seeds. The data submitted in support of the request were found to be sufficient to derive MRL proposals for linseeds, poppy seeds, mustard seeds and gold of pleasure seeds. For honey, however, data gaps were identified by EFSA and were not fully addressed by the justification provided by the applicant. Considering the remaining uncertainties, risk managers are given the option to either accept the justification provided and the related uncertainties or to merge the provided data with a data set from a previous application to derive an MRL proposal. Adequate analytical methods for enforcement are available to control the residues of acetamiprid in plant matrices and in honey at the validated limit of quantification (LOQ) of 0.01 mg/kg. Based on the risk assessment results, EFSA concluded that the short-term and long-term intake of residues resulting from the use of acetamiprid according to the reported agricultural practices is unlikely to present a risk to consumer health.

Indexed as

acetamipridconsumer risk assessmenthoneyMRLpesticidevarious oilseed crops

Identifiers

PMID36034320
PMCPMC9399826

What Socratic holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.